Under New York law, "strong policy considerations favor the enforcement of settlement agreements" because they preserve judicial resources and provide parties the autonomy to shape their own ...
SAN DIEGO, CA / ACCESSWIRE / August 1, 2023 / Plandai Biotechnology, Inc. ("Plandai" or the "Company") (OTC:PLPL) announces today the rescission of a material definitive agreement with Good Salt, LLC ...
Boca Raton, Florida--(Newsfile Corp. - March 24, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) ("Entero" or the "Company"), a clinical-stage biopharmaceutical company specializing in the ...
Clinical-stage biopharmaceutical company specializing in therapies for gastrointestinal diseases Entero Therapeutics (NASDAQ:ENTO) negotiated and signed a rescission agreement with 100% of the ...
OMAHA, Neb., March 19, 2026 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC: PAOG) today announced that James Schramm has resigned as Chief Executive Officer and that the Purchase and Sale Agreement dated ...
Vascepa (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. The effect of Vascepa on the risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results